Friday, May 17, 2019

Recommendations for Obtaining a Labeling Claim for Communicable Disease Donor Screening Tests Using Cadaveric Blood Specimens from Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)

Guidance for Industry: Recommendations for Obtaining a Labeling Claim for Communicable Disease Donor Screening Tests Using Cadaveric Blood Specimens from Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), CBER, Biologics, Development Stage, labeling, donor screening

via Whats New Vaccines Blood Biologics RSS Feed http://bit.ly/30sI0Tq

No comments:

Post a Comment